Literature DB >> 16460707

Release of GABA from sensory neurons transduced with a GAD67-expressing vector occurs by non-vesicular mechanisms.

Jun Liu1, Changfeng Tai, William C de Groat, Xiang-min Peng, Marina Mata, David J Fink.   

Abstract

We have demonstrated that dorsal root ganglion neurons transduced with a recombinant replication-defective herpes simplex virus vector coding for glutamic acid decarboxylase (QHGAD67) release GABA to produce an analgesic effect in rodent models of pain. In this study, we examined the mechanism of transgene-mediated GABA release from dorsal root ganglion neurons in vitro and in vivo. Release of GABA from dorsal root ganglion neurons transduced with QHGAD67 was not increased by membrane depolarization induced by 60 mM extracellular K+ nor reduced by the removal of Ca2+ from the medium. Release of GABA from transduced dorsal root ganglion neurons was, however, blocked in a dose-dependent manner by NO-711, a selective inhibitor of the GABA transporter-1. The amount of GABA released from a spinal cord slice preparation, prepared from animals transduced by subcutaneous inoculation of QHGAD67 in the hind paws, was substantially increased compared to animals transduced with control vector Q0ZHG or normal animals, but the amount of GABA released was not changed by stimulation of the dorsal roots at either low (0.1 mA, 0.5-ms duration) or high (10 mA, 0.5-ms duration) intensity. We conclude that QHGAD67-mediated GABA release from dorsal root ganglion neurons is non-vesicular, independent of electrical depolarization, and that this efflux is mediated through reversal of the GABA transporter.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460707     DOI: 10.1016/j.brainres.2005.12.091

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration.

Authors:  Xiangmin Peng; Zhigang Zhou; Jian Hu; David J Fink; Marina Mata
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

2.  Vector-mediated release of GABA attenuates pain-related behaviors and reduces Na(V)1.7 in DRG neurons.

Authors:  Munmun Chattopadhyay; Marina Mata; David J Fink
Journal:  Eur J Pain       Date:  2011-04-12       Impact factor: 3.931

Review 3.  HSV gene transfer in the treatment of chronic pain.

Authors:  David J Fink; Marina Mata
Journal:  Sheng Li Xue Bao       Date:  2008-10-25

4.  The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats.

Authors:  Xia Li; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2007-11-19       Impact factor: 5.250

Review 5.  Applications of gene therapy to the treatment of chronic pain.

Authors:  Marina Mata; Shuanglin Hao; David J Fink
Journal:  Curr Gene Ther       Date:  2008-02       Impact factor: 4.391

Review 6.  Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha.

Authors:  Marina Mata; Shuanglin Hao; David J Fink
Journal:  Neurosci Lett       Date:  2008-03-22       Impact factor: 3.046

7.  Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilateral 6-hydroxydopamine lesion.

Authors:  N Yamamoto; J-J Soghomonian
Journal:  Neuroscience       Date:  2008-04-16       Impact factor: 3.590

Review 8.  A clinical trial of gene therapy for chronic pain.

Authors:  Darren Wolfe; James Wechuck; David Krisky; Marina Mata; David J Fink
Journal:  Pain Med       Date:  2009-10       Impact factor: 3.750

Review 9.  A human trial of HSV-mediated gene transfer for the treatment of chronic pain.

Authors:  D Wolfe; M Mata; D J Fink
Journal:  Gene Ther       Date:  2009-02-26       Impact factor: 5.250

10.  Adenovector GAD65 gene delivery into the rat trigeminal ganglion produces orofacial analgesia.

Authors:  Jean-Philippe Vit; Peter T Ohara; Christopher Sundberg; Blanca Rubi; Pierre Maechler; Chunyan Liu; Mariana Puntel; Pedro Lowenstein; Maria Castro; Luc Jasmin
Journal:  Mol Pain       Date:  2009-08-05       Impact factor: 3.395

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.